throbber
CYAN EXHIBIT 1010
`
`Title: Transformation of astaxanthin to vitamin A in the albino rat: neoformation in
`vivo and in vitro.
`
`Authors: GRANGAUD, René; MASSONET, Renée; CONQUY, Thérese; RIDOLFO,
`J.
`
`Author Affiliation: Lab. Chim. biol., Fac. Med. Pharm., Algiers.
`Journal: Comptes Rendus de l'Academie des Sciences 1961 Vol. 252 pp. 1854-1856
`
`PHYSIOLOGY — Transformation of Astaxanthin into Vitamin A in the Albino Rat: Neo-formation
`
`in vivo and in vitro. Note (*) by Mr. Rene Grangaud, Ms. Renee Massonet, Madams Therese
`
`Conquy and Jacqueline Ridolfo, presented by Mr. Robert Courrier.
`
`In deficient rats, the per os administration of astaxanthin diacetate causes neoformation
`
`of vitamin A which is detectable in the eye. In vitro experimentation can be used to specify
`
`that this organ is the seat of the enzymatic transformation which converts astaxanthin to
`retinol.
`
`In vitamin A deficient albino rats, astaxanthin (3,3'-dihydroxy-4,4‘-diketo-[3-carotene) manifests a
`
`decidedly antixerophthalmic activity. In fact, the daily administration of 10 to 15 ug of pigment heals
`
`ocular lesions rapidly without resulting in weight increase which is only observed with much greater
`dosages (1) t° (4). In fish, however, astaxanthin is an authentic provitamin A because, in Gambusia
`holbrooki, it leads to a neoformation of retinol which is particularly detectable in the intestinal
`mucous <3)’ <6)’ (7). Confrontation of these facts suggests that the rat might have preserved the restricted
`ability, in the eye, of converting astaxanthin into vitamin A. This is, at least, the hypothesis which was
`
`subjected to experimental examination.
`
`In a first experiment, some astaxanthin diacetate was administered to vitamin A deficient rats which
`
`were then sacrificed at the same times as control rats and vitamin A was administered, in parallel, in
`
`the eyes of each category of subjects. In a second experiment, the eyes of deficient animals were
`
`divided into 2 lots: the first lot was incubated in the presence of astaxanthin diacetate, the second was
`
`treated in the same manner but without any addition of pigment; the respective concentrations of
`retinol were then determined.
`
`ASTAXANTHIN DIACETATE PREPARATION — The inner walls of the stomach pockets ofAr1'ste0m0rpha
`
`foliacea, Risso and Aristeus antennatus, Risso (jumbo red penaeid shrimp) contain a blue
`chromoprotein whose prosthetic group is astaxanthin (4). After dissection, the pockets were emptied
`of their contents and agitated with distilled water in which chromoprotein was dissolved. The solution
`
`was then diluted with four times its volume of acetone: the astaxanthin was detached from its protein
`
`copula and the solution turned an orange-red. With the addition of petrol ether and water, the pigment
`
`passed into the light phase which was separated and then dried on anhydrous sodium sulfate. The
`
`solution was filtered in a magnesium oxide column which was then washed with petrol ether, then
`
`with hexane diluted with 2% volume acetone (elimination of vitamin A carotenes and
`
`1854
`
`

`
`esters) and, finally, with a mix of 92 ml of hexane and 8 ml of ethanol (elimination of the retinol). The
`
`column was then sectioned, the pigmented zone was immersed in pyridine which, by elution, turned
`
`red. The concentrated solution under reduced pressure and under nitrogen was diluted with acetic
`
`anhydride (XX drops/ml). After 9 hours at ambient temperature, the diacetate was then treated by
`
`petrol ether. The solution was washed, dried and chromatographed on aluminum oxide. The column
`
`was processed similar to the magnesium oxide. The pyridinic solution which was obtained was diluted
`
`with petrol ether and water. The light phase was separated, dried and concentrated. The residue was
`
`treated with hot pyridine, diluted by a third volume of water and left for 24 hours at 0°C. The
`
`crystalline precipitate was purified by two re-crystallizations.
`
`PROTOCOL AND RESULTS. — a. In vivo experiment — 18 Wistar rats, weighing 32 g, were weaned and
`
`subjected to the base regime which was free of all vitamin A factors. After 40 days, the signs of
`
`deficiency were manifest, the animals were divided into 3 lots which received the following daily
`doses:
`
`Lot A: traces; lot B: 1 ug; lot C: 2.1 ug.
`
`b. In vitro experiments. — 12 deficient rats, under the same conditions as the preceding, were
`decapitated on the 40th day. 1 ml of blood serum and 1 mmole of or-tocopherol dispersed in 1 ml of
`water was placed into two small colloidion bags. The right eyes of 6 subjects and the left eyes of the
`
`other 6 subjects were placed into one of the bags (Lot 1).; The 12 remaining eyes and 1 mg of
`
`astaxanthin diacetate in dispersion in 1 ml of Tween 80 were placed into the other bag (Lot 11). The
`
`bags were immersed into a buffered Krebs-Ringer solution and kept in an oven at 37°C for 12 hours.
`
`The dosage of vitamin A produced in the unsaponifiable [tissues] of all the eyes of each lot provided
`
`the following values:
`
`Lot 1: 0.75 ug; Lot 11: 1.65ug.
`
`Discussion. — A spectrophotometric study of the pigment solution before chromatography did not
`
`reveal any vitamin A nor carotene. If traces of these substances had, however, escaped examination,
`
`they would have been eliminated by the washings of the columns performed for that purpose in
`
`accordance with (10). Re-crystallization of the astaxanthin diacetate constitutes a final purification.
`
`The following control excludes the interference of impurities: under the same conditions as that in the
`
`in Vitro experiment, two lots of deficient rat intestinal fragments were incubated, 1 lot in the presence
`
`of [3-carotene and the other in the presence of astaxanthin diacetate. Neoformation of vitamin A was
`
`only detected in the first lot.
`
`1855
`
`

`
`Thus, in the experimental conditions described, in vivo as well as for in vitro, neoformed and detected
`
`Vitamin A in the eye can only be due to astaxanthin transformation. Additional experiments will try to
`
`determine whether, since it is likely, it is the retina which performs the enzymatic conversion.
`
`Conclusion. — The recorded results Verify the working hypothesis which dictated these experiments:
`in Vitamin A deficient albino rats, the administration of astaxanthin diacetate causes neoformation of
`
`retinol in the eye. The in vitro experimentation led to the same results and also localized the reaction
`seat to the ocular tissue.
`
`(*) Meeting of 13 March 1961.
`(1) R.Grangaud and R. Massonet, C.R.Acad.Sc., 1948, V.227, p.568.
`(2) R.Grangaud and R. Massonet, C. R. Acad. Sc., 1950, V.230, p.1319.
`(3) R.Grangaud, Doctoral Thesis in Physical Sciences, Lyon, 1950.
`(4) Mlle R. Massonet, Doctoral Thesis in Natural Sciences, Lyon, 1958.
`(5) R.Grangaud and R. Massonet, C.R.Acad.Sc., V241, 1955, p. 1087.
`(6) R.Grangaud, P.Vignais, Mlle R. Massonet, and J.P.Moatti, C.R.Acad.Sc., V243, 1956, p.1170.
`(7) J .P.Moatti, State Doctoral Thesis (Pharmacy), Algiers, 1959.
`(8) 2% dot-tocopherol is added to a solution of deVitaminized Vegetable oil.
`(9) J.M.Lewis, O.Bodansky, K.G.Falk and G. McGuire, .1. Nutrition, v23, 1941, p.351.
`(10) S.Y.Thompson, J.Ganouly and S.K.KON, Brit. J. Nutr.,V.3, no.1, 1949, p. 57.
`
`(Laboratory of Biochemistry, Faculty of Medicine and Pharmacy of Algiers.)
`
`1856

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket